IXICO
Generated by Meeveem AI
"Leaders in AI-driven neuroimaging analytics for clinical trials"
London
•51 - 250 Employees
•Contract Research
About IXICO
IXICO specialises in neuroscience imaging and biomarker analytics for pharmaceutical clinical trials. The company uses AI to analyse brain scans and measure disease progression in neurological disorders such as Alzheimer's, Parkinson's, and Huntington's Disease. This data helps pharmaceutical companies assess drug safety and efficacy, select patients, and accelerate research. Operating as an imaging Contract Research Organisation, IXICO manages every stage from site setup to analysis and reporting. With two decades supporting hundreds of trials globally, the company provides regulatorily compliant endpoints that reduce uncertainty in drug development and improve decision making for researchers developing neurological treatments.
79
Team Members
2004
Founded
Contract Research
Sector
Hybrid
Work Environment
Our Vision
A world where neurological diseases are detected earlier, understood more completely, and treated more effectively through precision imaging insights that accelerate medical breakthroughs.
Our Mission
At IXICO, our mission is to advance medicine through the provision of precision imaging biomarker insights for the discovery, development and delivery of novel treatments in neurological disease.